SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q/A
Amendment No. 1 to
[X] Quarterly report pursuant to Section 13 or 15 (d) of the Securities
Exchange Act of 1934. For the quarterly period ended June 30, 1998.
[ ] Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934. For the transition period from _________ to
_________.
Commission File Number
0-26992
CARDIOVASCULAR DIAGNOSTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
North Carolina 56-1493744
(State or other jurisdiction of (IRS Employer Identification Number)
Incorporation or organization)
5301 Departure Drive
Raleigh, North Carolina 27616
(Address of Principal Executive Office) (Zip Code)
Registrant's Telephone Number, Including Area Code 919-954-9871
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. YES [X] NO [ ]
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Class Outstanding as of August 5, 1998
Common Stock, par value $.001 6,805,079
<PAGE>
Part II. OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders
The Annual Meeting of Shareholders of the Company was held on May 7, 1998. The
following is a description of the matters voted upon at the meeting and the
number of affirmative votes and negative votes cast with respect to each matter.
(a) The following persons were elected to the Company's Board of Directors.
The votes for, against (withheld) and abstentions were as follows:
Nominee Votes For Votes Withheld Votes Abstained
------- --------- -------------- ---------------
John P. Funkhouser 5,126,245 0 254,838
William A. Hawkins 5,131,308 0 249,775
John K. Pirotte 5,132,808 0 248,275
Stephen R. Puckett 5,366,308 0 14,775
Philip R. Tracy 5,132,308 0 248,775
(b) The shareholders ratified the appointment of Coopers & Lybrand L.L.P as
the independent auditors of the Company for the year ending December 31,
1998 with 5,380,708 shares voting for and 375 shares abstained.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CARDIOVASCULAR DIAGNOSTICS, INC.
Date: September 11, 1998 By: /s/ Paul Storey
-----------------------
Paul Storey
Treasurer
(Principal Financial and Accounting Officer)
